Alfresa's self-medication products wholesale business net sales FY 2014-2018
This statistic depicts the net sales of Alfresa Holdings Corporation's self-medication products wholesaling business from fiscal year 2014 to 2017, with a forecast for 2018. In fiscal 2018, the Japanese pharmaceutical company was forecast to reach net sales amounting to approximately 263 billion Japanese yen in the self-medication products wholesaling business, an increase from around 200 billion yen in fiscal year 2014.